These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15506053

  • 21. Novel cutaneous uses for botulinum toxin type A.
    Bansal C, Omlin KJ, Hayes CM, Rohrer TE.
    J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A, Rodrigues B, Nóbrega AC.
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract] [Full Text] [Related]

  • 23. Botulinum toxin a treatment in chronic daily headache.
    Cutrer FM.
    Headache; 2005 Apr; 45(4):270-1. PubMed ID: 15836560
    [No Abstract] [Full Text] [Related]

  • 24. Migraine, botulinum toxin type-A, and the disappearing sebaceous cyst.
    Turner IM, Agrillo T.
    Headache; 2005 Feb; 45(2):166-7. PubMed ID: 15705125
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin in dermatology - beyond wrinkles and sweat.
    Diamond A, Jankovic J.
    J Cosmet Dermatol; 2006 Jun; 5(2):169. PubMed ID: 17173593
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Botulinum toxin a in the overactive bladder: current status and future directions.
    Mallina R, Sahai A, Khan MS, Dasgupta P.
    BJU Int; 2007 Jun; 99(6):1549-50. PubMed ID: 17537223
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM, Arbel N.
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract] [Full Text] [Related]

  • 36. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
    Seiff SR, Zwick OM.
    Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
    Aburahma SK, Al-Khateeb T, Alrefai A, Amarin Z.
    J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.